what this node claims
AlphaFold metrics / KISS1R
Model-quality receipt for the fold. It is not biological validation.
vertical proof spine
evidence / risk instrument
52%
low debt pressure
21%
75%structureusable
pLDDT 75.26
78%evidenceusable
grade B
0%gatesdebt
0/5 gates
100%riskstrong
0 hard flags
22%exportdebt
no export
33%lineagedebt
incomplete spine
proof completeness
33% missing target, candidate, finding, export- 01 target
- 02 fold
- 03 alphafold metric
- 04 candidate
- 05 finding
- 06 export
Metrics and receipt inputs
- confidence band
- confident
- confidence pct
- 75.26
- coverage context
- missing or not linked
- interpretation
- usable fold context with explicit model-confidence limits
- pae context
- missing or not linked
- plddt avg
- 75.26
- sequence length
- 0
AlphaFold metrics visual
Confident backbone model
398 residues / min 28.05 / max 98.25 / source alphafold db
Very high
33.2%
132 residues / >=90
Confident
35.2%
140 residues / 70-89
Low
10.3%
41 residues / 50-69
Very low
21.4%
85 residues / <50
usable fold context with explicit model-confidence limits
Near-complete coverage / observed 398 of 398 residues.
- residues 336-398 / mean 45.44
- residues 1-38 / mean 38.18
- residues 235-244 / mean 64.47
- residues 290-297 / mean 58.18
proof debt register
21%
Visible limits, not hidden cleanup.
Peptide RX keeps unresolved proof debt attached to the public receipt. Some debts should be resolved; redaction and research-use boundaries should stay visible.